CClinicalTrials.gg
CompletedNCT04966039Updated Jul 19, 2021

Diffusion Weighted Magnetic Resonance Imaging of Brain in Monochorionic Twin Pregnancies With Demise of One Fetus

An observational study in Twin Pregnancy With Antenatal Problem, sponsored by Peking University Third Hospital. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2021-07-19.

Sponsored by Peking University Third Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
60
01

Study summary

Diffusion weighted imaging (DWI) can reflect the microstructure and pathological changes of tissue, and diffusion tensor imaging (DTI) can quantitatively evaluate the fine structure of white matter in brain. In this study, conventional and diffusion-weighted MRI (DWI, DTI) sequences were used to analyze the brain of monochorionic twin pregnancies with demise of one fetus.

Read the detailed description

With the incidence rate of twin pregnancy increasing, the incidence of intrauterine death of twin pregnancies is also rising, which has great impact on the morbidity and mortality of the other fetus, and increases the mortality of fetal survival, premature birth, brain damage and long-term sequela. Therefore, it is necessary to examine the central nervous system of the surviving fetus of twin pregnancy and intrauterine death. When the surviving fetus is complicated with nervous system abnormalities, conventional MRI can generally make a diagnosis. However, some of the surviving fetuses may not find other structural or echo abnormalities on B-mode ultrasonography, and even these fetuses do not find structural or signal abnormalities on routine MRI examination. Whether the surviving fetuses may have brain abnormalities cannot be detected early by the above methods. Diffusion weighted imaging (DWI) can reflect the microstructure and pathological changes of tissue, and diffusion tensor imaging (DTI) can quantitatively evaluate the fine structure of white matter in brain.

The present study is to use conventional sequence and diffusion-weighted imaging (DWI, DTI) to analyze the brain of monochorionic twin pregnancies with demise of one fetus, which aims to find the potential brain abnormalities early and provide some guidance for the clinical diagnosis and treatment in the next step.

02

Conditions studied

  • Twin Pregnancy With Antenatal Problem

Browse trials for

Keywords

  • twin pregnancy
  • demise of one fetus
  • Diffusion weighted imaging
  • Diffusion tensor imaging
03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's enrollment of 60 is below the median of 140 across 238 observational studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

Peking University Third Hospital is the lead sponsor of 735 studies on the registry; 262 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sampling method
Non-probability sample

Study population

  1. Twin pregnancy was diagnosed and one fetus died in utero
  2. Twin pregnancy with one abnormal fetus
  3. Singleton pregnancy with abnormalities outside the fetal brain

Inclusion criteria

  1. Twin pregnancy was diagnosed and one fetus died in utero
  2. Twin pregnancy with one abnormal fetus
  3. Singleton pregnancy with abnormalities outside the fetal brain

Exclusion criteria

Exclusion Criteria:

  1. Those who can't cooperate with MRI examination, such as those who have metal, claustrophobia or can't insist on scanning.
  2. Pregnant women with gestational age less than 20 weeks.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • monochorionic twin pregnancies with demise of one fetus

    Twin pregnancy was diagnosed and one fetus died in utero, 20 pregnant women

    Other: No intervention.

  • Twin control group

    Twin pregnancy with one abnormal fetus, 20 pregnant women

    Other: No intervention.

  • Singleton control group

    Singleton pregnancy with abnormalities outside the fetal brain, 20 pregnant women

    Other: No intervention.

Interventions

  • OtherNo intervention.

    There was no intervention.

06

What researchers measure

Primary outcomes

  1. basic information

    age

    Time frame: baseline

  2. basic information

    gestational age

    Time frame: baseline

  3. basic information

    uterine height

    Time frame: baseline

  4. basic information

    abdominal circumference

    Time frame: baseline

  5. basic information

    intrauterine death time of one fetus

    Time frame: baseline

  6. MRI

    DWI sequence (ADC value)

    Time frame: baseline

  7. MRI

    DTI sequence (FA value)

    Time frame: baseline

  8. MRI

    conventional sequence

    Time frame: baseline

07

Study locations

1 site
  • Peking University Third Hospital
    Beijing, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04966039
Lead sponsor
Peking University Third Hospital
Responsible party
Sponsor
First posted
Jul 19, 2021
Start date
Jan 1, 2018
Primary completion
Dec 31, 2020
Completion
Dec 31, 2020
Last update
Jul 19, 2021

Study contacts

Ying Liu, Dr.
principal investigator · Peking University Third Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion